HIV-associated nephropathy: Case study and review of the literature

Michael J. Ross, Paul E. Klotman, Jonathan A. Winston

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Human immunodeficiency virus type 1 (HIV-1)-seropositive patients are at risk for the development of a variety of acute and chronic renal diseases. The most common cause of chronic renal failure in HIV-1-seropositive patients is HIV-associated nephropathy (HIVAN). HIVAN occurs almost exclusively in black patients and the majority of published cases are of patients who present with acquired immunodeficiency syndrome (AIDS). This disease is currently the third leading cause of end-stage renal disease in blacks aged 20-64. Because HIV-1-seropositive patients may develop a wide variety of acute and chronic renal diseases, definitive diagnosis requires renal biopsy. Emerging data suggest a direct role of HIV-1 infection of kidney cells in the pathogenesis of HIVAN. There have been no well-controlled clinical trials in the treatment of HIVAN. The therapeutic agents with the most promise are angiotensin-converting enzyme inhibitors and antiretroviral medications. Long-term renal prognosis may be changing in the setting of improved aggressive antiretroviral therapy. Patient survival is determined primarily by the stage of HIV-1 infection. In this article, we present the case history of a patient who developed HIVAN. We then review the current literature concerning the epidemiology, differential diagnosis, etiology, and treatment of HIVAN.

Original languageEnglish (US)
Pages (from-to)637-645
Number of pages9
JournalAIDS Patient Care and STDs
Volume14
Issue number12
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

AIDS-Associated Nephropathy
HIV-1
Virus Diseases
Chronic Renal Insufficiency
Kidney
Chronic Kidney Failure
Controlled Clinical Trials
Therapeutics
Angiotensin-Converting Enzyme Inhibitors
Acquired Immunodeficiency Syndrome
Epidemiology
Differential Diagnosis
Biopsy
Survival

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

HIV-associated nephropathy : Case study and review of the literature. / Ross, Michael J.; Klotman, Paul E.; Winston, Jonathan A.

In: AIDS Patient Care and STDs, Vol. 14, No. 12, 2000, p. 637-645.

Research output: Contribution to journalArticle

Ross, Michael J. ; Klotman, Paul E. ; Winston, Jonathan A. / HIV-associated nephropathy : Case study and review of the literature. In: AIDS Patient Care and STDs. 2000 ; Vol. 14, No. 12. pp. 637-645.
@article{7efd636fb32c47b9a78b3349c23a446f,
title = "HIV-associated nephropathy: Case study and review of the literature",
abstract = "Human immunodeficiency virus type 1 (HIV-1)-seropositive patients are at risk for the development of a variety of acute and chronic renal diseases. The most common cause of chronic renal failure in HIV-1-seropositive patients is HIV-associated nephropathy (HIVAN). HIVAN occurs almost exclusively in black patients and the majority of published cases are of patients who present with acquired immunodeficiency syndrome (AIDS). This disease is currently the third leading cause of end-stage renal disease in blacks aged 20-64. Because HIV-1-seropositive patients may develop a wide variety of acute and chronic renal diseases, definitive diagnosis requires renal biopsy. Emerging data suggest a direct role of HIV-1 infection of kidney cells in the pathogenesis of HIVAN. There have been no well-controlled clinical trials in the treatment of HIVAN. The therapeutic agents with the most promise are angiotensin-converting enzyme inhibitors and antiretroviral medications. Long-term renal prognosis may be changing in the setting of improved aggressive antiretroviral therapy. Patient survival is determined primarily by the stage of HIV-1 infection. In this article, we present the case history of a patient who developed HIVAN. We then review the current literature concerning the epidemiology, differential diagnosis, etiology, and treatment of HIVAN.",
author = "Ross, {Michael J.} and Klotman, {Paul E.} and Winston, {Jonathan A.}",
year = "2000",
doi = "10.1089/10872910050206559",
language = "English (US)",
volume = "14",
pages = "637--645",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "12",

}

TY - JOUR

T1 - HIV-associated nephropathy

T2 - Case study and review of the literature

AU - Ross, Michael J.

AU - Klotman, Paul E.

AU - Winston, Jonathan A.

PY - 2000

Y1 - 2000

N2 - Human immunodeficiency virus type 1 (HIV-1)-seropositive patients are at risk for the development of a variety of acute and chronic renal diseases. The most common cause of chronic renal failure in HIV-1-seropositive patients is HIV-associated nephropathy (HIVAN). HIVAN occurs almost exclusively in black patients and the majority of published cases are of patients who present with acquired immunodeficiency syndrome (AIDS). This disease is currently the third leading cause of end-stage renal disease in blacks aged 20-64. Because HIV-1-seropositive patients may develop a wide variety of acute and chronic renal diseases, definitive diagnosis requires renal biopsy. Emerging data suggest a direct role of HIV-1 infection of kidney cells in the pathogenesis of HIVAN. There have been no well-controlled clinical trials in the treatment of HIVAN. The therapeutic agents with the most promise are angiotensin-converting enzyme inhibitors and antiretroviral medications. Long-term renal prognosis may be changing in the setting of improved aggressive antiretroviral therapy. Patient survival is determined primarily by the stage of HIV-1 infection. In this article, we present the case history of a patient who developed HIVAN. We then review the current literature concerning the epidemiology, differential diagnosis, etiology, and treatment of HIVAN.

AB - Human immunodeficiency virus type 1 (HIV-1)-seropositive patients are at risk for the development of a variety of acute and chronic renal diseases. The most common cause of chronic renal failure in HIV-1-seropositive patients is HIV-associated nephropathy (HIVAN). HIVAN occurs almost exclusively in black patients and the majority of published cases are of patients who present with acquired immunodeficiency syndrome (AIDS). This disease is currently the third leading cause of end-stage renal disease in blacks aged 20-64. Because HIV-1-seropositive patients may develop a wide variety of acute and chronic renal diseases, definitive diagnosis requires renal biopsy. Emerging data suggest a direct role of HIV-1 infection of kidney cells in the pathogenesis of HIVAN. There have been no well-controlled clinical trials in the treatment of HIVAN. The therapeutic agents with the most promise are angiotensin-converting enzyme inhibitors and antiretroviral medications. Long-term renal prognosis may be changing in the setting of improved aggressive antiretroviral therapy. Patient survival is determined primarily by the stage of HIV-1 infection. In this article, we present the case history of a patient who developed HIVAN. We then review the current literature concerning the epidemiology, differential diagnosis, etiology, and treatment of HIVAN.

UR - http://www.scopus.com/inward/record.url?scp=0033674556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033674556&partnerID=8YFLogxK

U2 - 10.1089/10872910050206559

DO - 10.1089/10872910050206559

M3 - Article

C2 - 11119430

AN - SCOPUS:0033674556

VL - 14

SP - 637

EP - 645

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 12

ER -